Dr. Reddy's Laboratories, Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's L…

Recall date

April 23, 2018

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0727-2018

FDA classification

Class II

Brand / firm

Dr. Reddy's Laboratories, Inc.

Sold / distributed

Nationwide

Why it was recalled

Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01